The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals.

Alzheimer's disease Alzheimer's disease signature apolipoprotein E ε2 carrier brain maintenance brain morphology brain reserve cognitive reserve magnetic resonance multi-site resilience signature

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
07 2022
Historique:
revised: 23 06 2021
received: 30 03 2021
accepted: 01 09 2021
pubmed: 9 12 2021
medline: 20 7 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

Harboring two copies of the apolipoprotein E (APOE) ε2 allele strongly protects against Alzheimer's disease (AD). However, the effect of this genotype on gray matter (GM) volume in cognitively unimpaired individuals has not yet been described. Multicenter brain magnetic resonance images (MRIs) from cognitively unimpaired ε2 homozygotes were matched (1:1) against all other APOE genotypes for relevant confounders (n = 223). GM volumes of ε2 genotypic groups were compared to each other and to the reference group (APOE ε3/ε3). Carrying at least one ε2 allele was associated with larger GM volumes in brain areas typically affected by AD and also in areas associated with cognitive resilience. APOE ε2 homozygotes, but not APOE ε2 heterozygotes, showed larger GM volumes in areas related to successful aging. In addition to the known resistance against amyloid-β deposition, the larger GM volumes in key brain regions may confer APOE ε2 homozygotes additional protection against AD-related cognitive decline.

Identifiants

pubmed: 34877786
doi: 10.1002/alz.12487
pmc: PMC9542211
doi:

Substances chimiques

Apolipoprotein E2 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383-1395

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

J Neurosci. 2012 Oct 24;32(43):15181-92
pubmed: 23100439
J Alzheimers Dis. 2011;26 Suppl 3:49-60
pubmed: 21971450
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6820-5
pubmed: 19346482
Arch Neurol. 2007 Aug;64(8):1193-6
pubmed: 17698712
Neurobiol Aging. 2012 Dec;33(12):2723-32
pubmed: 22405043
Brain. 2019 Apr 1;142(4):1134-1147
pubmed: 30851100
Nat Rev Neurosci. 2009 May;10(5):333-44
pubmed: 19339974
Eur J Epidemiol. 2019 Feb;34(2):191-209
pubmed: 30421322
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82
pubmed: 21157852
Neurosci Lett. 2010 Aug 2;479(3):332-6
pubmed: 20573574
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8299-302
pubmed: 15932949
J Neurosci. 2016 Sep 14;36(37):9659-68
pubmed: 27629716
Brain. 2016 May;139(Pt 5):1551-67
pubmed: 26962052
Alzheimers Dement (N Y). 2016 Mar 03;2(2):82-92
pubmed: 29067295
J Alzheimers Dis. 2011;26(2):207-10
pubmed: 21606569
JAMA Neurol. 2021 Feb 1;78(2):229-235
pubmed: 33044487
J Alzheimers Dis. 2018;62(3):1091-1111
pubmed: 29562540
BMJ Open. 2019 Dec 18;9(12):e030379
pubmed: 31857299
Alzheimers Dement. 2022 Jul;18(7):1383-1395
pubmed: 34877786
Alzheimers Dement. 2018 Jul;14(7):902-912
pubmed: 29605385
JAMA. 1997 Oct 22-29;278(16):1349-56
pubmed: 9343467
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2212-2224
pubmed: 33521872
Neurology. 2009 Mar 3;72(9):829-34
pubmed: 19255410
Dement Geriatr Cogn Disord. 2010;30(3):229-37
pubmed: 20847553
Lancet Neurol. 2007 Jun;6(6):494-500
pubmed: 17509484
Nature. 2017 Sep 28;549(7673):523-527
pubmed: 28959956
Mol Neurodegener. 2020 Nov 4;15(1):63
pubmed: 33148290
Brain. 2015 Dec;138(Pt 12):3747-59
pubmed: 26428666
Neurology. 2017 Feb 7;88(6):569-576
pubmed: 28062720
Alzheimers Res Ther. 2018 Aug 7;10(1):76
pubmed: 30081935
Nat Rev Neurol. 2019 Sep;15(9):501-518
pubmed: 31367008
Nat Rev Neurol. 2013 Feb;9(2):106-18
pubmed: 23296339
J Alzheimers Dis. 2009;18(3):553-64
pubmed: 19584447
J Alzheimers Dis. 2014;40(1):37-43
pubmed: 24326516
Nat Protoc. 2011 Feb;6(2):121-33
pubmed: 21293453
Alzheimers Dement. 2020 Sep;16(9):1305-1311
pubmed: 30222945
Hippocampus. 2017 Jun;27(6):653-667
pubmed: 28394034
J Cogn Neurosci. 2007 Sep;19(9):1498-507
pubmed: 17714011
Neurology. 2018 Nov 13;91(20):e1851-e1859
pubmed: 30341156
Cereb Cortex. 2009 Mar;19(3):497-510
pubmed: 18632739
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2878-86
pubmed: 24183852
JAMA. 2015 May 19;313(19):1924-38
pubmed: 25988462
Nat Commun. 2020 Feb 3;11(1):667
pubmed: 32015339

Auteurs

Gemma Salvadó (G)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Daniel Ferreira (D)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Grégory Operto (G)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.

Irene Cumplido-Mayoral (I)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.

Eider M Arenaza-Urquijo (EM)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.

Raffaele Cacciaglia (R)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.

Carles Falcon (C)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Natàlia Vilor-Tejedor (N)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.
Department of Clinical Genetics, ERASMUS MC, Rotterdam, the Netherlands.

Carolina Minguillon (C)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.

Colin Groot (C)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Wiesje M van der Flier (WM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Department of Epidemiology & Biostatistics, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Frederik Barkhof (F)

Department of Radiology and Nuclear Medicine, VU Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
Institutes of Neurology & Healthcare Engineering, University College London, London, UK.

Philip Scheltens (P)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Rik Ossenkoppele (R)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Clinical Memory Research Unit, Lund University, Lund, Sweden.

Silke Kern (S)

Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg, Gothenburg, Sweden.

Anna Zettergren (A)

Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg, Gothenburg, Sweden.

Ingmar Skoog (I)

Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg, Gothenburg, Sweden.

Jakub Hort (J)

International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic.
Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.

Erik Stomrud (E)

Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.

Danielle van Westen (D)

Diagnostic Radiology, Institution for Clinical Sciences, Lund University, Lund, Sweden.
Image and Function, Skåne University Hospital, Lund, Sweden.

Oskar Hansson (O)

Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.

José Luis Molinuevo (JL)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.

Lars-Olof Wahlund (LO)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Eric Westman (E)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Juan Domingo Gispert (JD)

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH